Njira Lugogo, MD
Enriched profileClinical Professor of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School · University of Michigan
Njira Lugogo is Clinical Professor of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School at University of Michigan. OpenAlex indexes 497 publications with 9,051 citations (h-index 45); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Njira Lugogo, M.D., is Clinical Professor of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School. The public record shows 497 publications with 9,051 citations (h-index 45), centered on Asthma and respiratory diseases, Inhalation and Respiratory Drug Delivery, Respiratory and Cough-Related Research. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 18 companies.
- Most recent indexed publication: 2026 · Journal of asthma and allergy
- Top research focus: Asthma and respiratory diseases
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 18 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 101.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
Industry payments
Updated 27 Aug 2026
18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202551 payments$50,277openpaymentsdata.cms.gov ↗
- AstraZeneca UK LimitedProgram year202513 payments$37,882openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20257 payments$16,400openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
64.8%Corticosteroid27%Trelegy Ellipta48%Symbicort14%Budesonide-Formoterol Fumarate13%Breo Ellipta8%Breztri Aerosphere6%Dulera5%Fluticasone Propionate4%Breyna3%Part D<11 patientsThymic Stromal Lymphopoietin Blocker10.7%Tezspire100%Part D≥21 patientsDermatology
14%Interleukin-4 Receptor alpha Antagonist14%Dupixent Pen50%Dupixent Syringe50%Part D<11 patientsMetabolism & gastrointestinal
10.8%Corticosteroid10.8%Prednisone100%Part D≥52 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Mortality Among Adults with Subspecialist-Treated Severe Asthma: A Descriptive Analysis from the Observational CHRONICLE Study.
Journal of asthma and allergy
Article2026 - Normal FEV(1) without Reversibility in Asthma Trials: A Placebo Patient-Level Meta-Analysis.
American journal of respiratory and critical care medicine
Letter2025 - The Rapidly Evolving Landscape of Asthma Therapies Is Exhilarating, Yet a Lack of Innovation in Clinical Trial Design Makes Feasibility a Real Concern.
American journal of respiratory and critical care medicine
Comment2025 - Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry.
Journal of asthma and allergy
Article2024 - Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types.
Journal of asthma and allergy
Review2024
Most-cited works
by citation count (OpenAlex)- 01Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe AsthmaArticle1,046 citations2017
- 02Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19Article646 citations2020
- 03Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary DiseaseArticle603 citations2017
- 04Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled AsthmaArticle512 citations2010
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/njira-lugogo-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Google Scholar
scholar.google.com/citations
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholar.google.com ↗ - X / Twitter
x.com/DocLugogo
Mentions by others
where others cite or feature them- Facebook
facebook.com/MichiganMedicine/videos/treating-severe-asthma/1623441754790313
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Instagram
instagram.com/reel/DPonmnJj5MN
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗ - LinkedIn
linkedin.com/posts/circassia_professor-njira-lugogo-the-science-behind-activity-7110903146020753409-sSHt
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medschool.umich.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →site.thoracic.org ↗
- B.S.
Human Nutrition and Foods, Virginia Polytechnic Institute and State University (Virginia Tech)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →site.thoracic.org ↗ - Internal Medicine Residency
Wake Forest University Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →site.thoracic.org ↗ - Pulmonary and Critical Care Medicine Fellowship
Duke University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →site.thoracic.org ↗ - Board certified
Pulmonary Disease
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Editorial & leadership roles
journal and society appointments- Asthma Program Director
Division of Pulmonary & Critical Care Medicine, University of Michigan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →site.thoracic.org ↗ - Medical Director
Michigan Clinical Research Unit
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →site.thoracic.org ↗ - Medical Director
INHALE (Michigan statewide asthma/COPD quality-improvement initiative)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →site.thoracic.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajmc.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan